57G-21264-93747
3 vaccinations
10 coded responses
24 check-ins
10 free-text entries
6 call cases
- Sex
- Male
- Age at first dose
- 31-35
- ZIP prefix
- 021 / MA
- Registered
- 2021-01-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Dose 1 — Pfizer-BioNTech
-
2021-01-31
Registered in v-safe
-
2021-01-31
Survey response — day 14, dose 1MedDRA: Injection site dryness, Injection site reaction — Feeling: FairFree text: Arm having localized reaction. Started as small hole and dry skin at site of injection on day 7, has gotten bigger and deeper but doesnt hurt and isnt draining anything.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Survey response — day 21, dose 1MedDRA: Erythema, Injection site erythema, Injection site swelling, Rash, Rash erythematous, Rash papular — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Diffuse rash: clusters of small red raised bumps & red skin around them, located above left armpit, on left ribcage around stomach to back, & right forearm. Less on legs/chest (1-5 bumps each). Local injection site red/swell still growing in diameterMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-09
Dose 2 — Pfizer-BioNTech
-
2021-02-12
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction, Office visit, Pityriasis rosea, Reaction to previous exposure to any vaccine — Feeling: Fair · Site: Pain, Swelling · Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Systemic reaction (other): I was diagnosed as having a very rare immune reaction to the first dose. (severe Pityriasis rosea full body). Nonetheless, I received the second dose and the rash has gotten somewhat worse. Derm COVID/VAX specialists are following up with me. We have decided to treat with steroid cream and Allegra 2x per day without anti-viral to ensure vaccine efficacy. · Healthcare visit (other): Specialist virtual visit with high resolution photos provided to physician prior to meetingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-13
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: Fair · Site: Pain · Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Please see prior note on last report.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-13
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-14
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: Fair · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Systemic reaction (other): See prior report · Healthcare visit (other): See prior reportMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-14
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-15
Survey response — days 1–6 daily, dose 2MedDRA: Type IV hypersensitivity reaction, Unevaluable event — Feeling: Fair · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Systemic reaction (other): See prior comment - diagnosed as delayed immune reaction to 1st dose, still persists and spreading. · Healthcare visit (other): See prior report.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-15
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-16
Survey response — day 7, dose 2MedDRA: Unevaluable event — Feeling: Fair · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: See prior report for detailsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Report sent to call center — day 7, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-23
Survey response — day 14, dose 2MedDRA: Rash — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Worsening rashMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-23
Report sent to call center — day 14, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-03-23
- 2021-05-11
- 2021-07-31
- 2021-08-10
-
2022-02-18
Dose 3 — Pfizer-BioNTech
-
2022-02-19
Survey response — days 1–6 daily, dose 3MedDRA: Bone pain, Hyperhidrosis — Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: deep bone pain & sweatsMedDRA releases: 2024-11 · check-in free text available
-
2022-02-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2022-02-21
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tiredness, DiarrheaAdult check-in
- 2022-02-22
- 2022-02-25
-
2022-03-04
Survey response — day 14, dose 3MedDRA: Fatigue — Feeling: Good · Be unable to do your normal daily activitiesFree text: FatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-03-11
- 2022-03-18
- 2022-05-20
- 2022-08-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Pfizer-BioNTech | |
| 2 | 2021-02-09 | Pfizer-BioNTech | |
| 3 | 2022-02-18 | Pfizer-BioNTech | No |
Call center
6 call center cases
6 unsuccessful
1 wait over 3 months for a first call
Free text
Release 3 — day 14, dose 1
Symptoms: Arm having localized reaction. Started as small hole and dry skin at site of injection on day 7, has gotten bigger and deeper but doesnt hurt and isnt draining anything.
Release 3 — day 21, dose 1
Symptoms: Diffuse rash: clusters of small red raised bumps & red skin around them, located above left armpit, on left ribcage around stomach to back, & right forearm. Less on legs/chest (1-5 bumps each). Local injection site red/swell still growing in diameter cut off by CDC
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): I was diagnosed as having a very rare immune reaction to the first dose. (severe Pityriasis rosea full body). Nonetheless, I received the second dose and the rash has gotten somewhat worse. Derm COVID/VAX specialists are following up with me. We have decided to treat with steroid cream and Allegra 2x per day without anti-viral to ensure vaccine efficacy.
Healthcare visit (other): Specialist virtual visit with high resolution photos provided to physician prior to meeting
Systemic reaction (other): Please see prior note on last report.
Systemic reaction (other): See prior comment - diagnosed as delayed immune reaction to 1st dose, still persists and spreading.
Healthcare visit (other): See prior report.
Release 4 — day 7, dose 2
Systemic reaction (other): See prior report for details
Release 4 — day 14, dose 2
Symptoms: Worsening rash
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): deep bone pain & sweats
Release 11 — day 14, dose 3
Symptoms: Fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Erythema | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Injection site dryness | ✓ | ✓ | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site reaction | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Rash erythematous | ✓ | ✓ | ✓ |
| SD | Rash papular | ✓ | ✓ | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Bone pain | · | · | ✓ |
| SRO | Hyperhidrosis | · | · | ✓ |
| SRO | Pityriasis rosea | ✓ | ✓ | ✓ |
| SRO | Reaction to previous exposure to any vaccine | ✓ | ✓ | ✓ |
| SRO | Type IV hypersensitivity reaction | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release